Kyoungrae Kim, Tomas A Cort, Eric M Kunz, Jack Moerschel, Victoria R Palzkill, Gengfu Dong, Chatick N Moparthy, Erik M Anderson, Brian Fazzone, Kerri A O'Malley, Scott T Robinson, Scott A Berceli, Terence E Ryan, Salvatore T Scali
{"title":"<i>N</i>-acetylcysteine treatment attenuates hemodialysis access-related limb pathophysiology in mice with chronic kidney disease.","authors":"Kyoungrae Kim, Tomas A Cort, Eric M Kunz, Jack Moerschel, Victoria R Palzkill, Gengfu Dong, Chatick N Moparthy, Erik M Anderson, Brian Fazzone, Kerri A O'Malley, Scott T Robinson, Scott A Berceli, Terence E Ryan, Salvatore T Scali","doi":"10.1152/ajprenal.00083.2023","DOIUrl":"10.1152/ajprenal.00083.2023","url":null,"abstract":"<p><p>The objective of the present study was to determine if treatment with <i>N</i>-acetylcysteine (NAC) could reduce access-related limb dysfunction in mice. Male and female C57BL6J mice were fed an adenine-supplemented diet to induce chronic kidney disease (CKD) prior to the surgical creation of an arteriovenous fistula (AVF) in the iliac vascular bundle. AVF creation significantly increased peak aortic and infrarenal vena cava blood flow velocities, but NAC treatment had no significant impact, indicating that fistula maturation was not impacted by NAC treatment. Hindlimb muscle and paw perfusion recovery and muscle capillary density in the AVF limb were unaffected by NAC treatment. However, NAC treatment significantly increased the mass of the tibialis anterior (<i>P</i> = 0.0120) and soleus (<i>P</i> = 0.0452) muscles post-AVF. There was a significant main effect of NAC treatment on hindlimb grip strength at <i>postoperative day 12</i> (<i>POD 12</i>) (<i>P</i> = 0.0003), driven by significantly higher grip strength in both male (<i>P</i> = 0.0273) and female (<i>P</i> = 0.0031) mice treated with NAC. There was also a significant main effect of NAC treatment on the walking speed at <i>postoperative day 12</i> (<i>P</i> = 0.0447), and post hoc testing revealed an improvement in NAC-treated male mice (<i>P</i> = 0.0091). The area of postsynaptic acetylcholine receptors (<i>P</i> = 0.0263) and motor endplates (<i>P</i> = 0.0240) was also increased by NAC treatment. Interestingly, hindlimb skeletal muscle mitochondrial oxidative phosphorylation trended higher in NAC-treated female mice but was not statistically significant (<i>P</i> = 0.0973). Muscle glutathione levels and redox status were not significantly impacted by NAC treatment in either sex. In summary, NAC treatment attenuated some aspects of neuromotor pathology in mice with chronic kidney disease following AVF creation.<b>NEW & NOTEWORTHY</b> Hemodialysis via autogenous arteriovenous fistula (AVF) is the preferred first-line modality for renal replacement therapy in patients with end-stage kidney disease. However, patients undergoing AVF surgery frequently experience a spectrum of hand disability symptoms postsurgery including weakness and neuromotor dysfunction. Unfortunately, no treatment is currently available to prevent or mitigate these symptoms. Here, we provide evidence that daily <i>N</i>-acetylcysteine supplementation can attenuate some aspects of limb neuromotor function in a preclinical mouse model of AVF.</p>","PeriodicalId":7588,"journal":{"name":"American Journal of Physiology-renal Physiology","volume":"325 3","pages":"F271-F282"},"PeriodicalIF":3.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10149809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kayo Okamura, Sizhao Lu, Zhibin He, Chris Altmann, John R Montford, Amy S Li, M Scott Lucia, David J Orlicky, Mary Weiser-Evans, Sarah Faubel
{"title":"IL-6 mediates the hepatic acute phase response after prerenal azotemia in a clinically defined murine model.","authors":"Kayo Okamura, Sizhao Lu, Zhibin He, Chris Altmann, John R Montford, Amy S Li, M Scott Lucia, David J Orlicky, Mary Weiser-Evans, Sarah Faubel","doi":"10.1152/ajprenal.00267.2022","DOIUrl":"10.1152/ajprenal.00267.2022","url":null,"abstract":"<p><p>Prerenal azotemia (PRA) is a major cause of acute kidney injury and uncommonly studied in preclinical models. We sought to develop and characterize a novel model of PRA that meets the clinical definition: acute loss of glomerular filtration rate (GFR) that returns to baseline with resuscitation. Adult male C57BL/6J wild-type (WT) and <i>IL-6</i><sup>-/-</sup> mice were studied. Intraperitoneal furosemide (4 mg) or vehicle was administered at time = 0 and 3 h to induce PRA from volume loss. Resuscitation began at 6 h with 1 mL intraperitoneal saline for four times for 36 h. Six hours after furosemide administration, measured glomerular filtration rate was 25% of baseline and returned to baseline after saline resuscitation at 48 h. After 6 h of PRA, plasma interleukin (IL)-6 was significantly increased, kidney and liver histology were normal, kidney and liver lactate were normal, and kidney injury molecule-1 immunofluorescence was negative. There were 327 differentially regulated genes upregulated in the liver, and the acute phase response was the most significantly upregulated pathway; 84 of the upregulated genes (25%) were suppressed in <i>IL-6</i><sup>-/-</sup> mice, and the acute phase response was the most significantly suppressed pathway. Significantly upregulated genes and their proteins were also investigated and included serum amyloid A2, serum amyloid A1, lipocalin 2, chemokine (C-X-C motif) ligand 1, and haptoglobin; hepatic gene expression and plasma protein levels were all increased in wild-type PRA and were all reduced in <i>IL-6</i><sup>-/-</sup> PRA. This work demonstrates previously unknown systemic effects of PRA that includes IL-6-mediated upregulation of the hepatic acute phase response.<b>NEW & NOTEWORTHY</b> Prerenal azotemia (PRA) accounts for a third of acute kidney injury (AKI) cases yet is rarely studied in preclinical models. We developed a clinically defined murine model of prerenal azotemia characterized by a 75% decrease in measured glomerular filtration rate (GFR), return of measured glomerular filtration rate to baseline with resuscitation, and absent tubular injury. Numerous systemic effects were observed, such as increased plasma interleukin-6 (IL-6) and upregulation of the hepatic acute phase response.</p>","PeriodicalId":7588,"journal":{"name":"American Journal of Physiology-renal Physiology","volume":"325 3","pages":"F328-F344"},"PeriodicalIF":3.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10412409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matthijs Luxen, Peter J Zwiers, Femke Meester, Rianne M Jongman, Timara Kuiper, Jill Moser, Marianne Pultar, Susanna Skalicky, Andreas B Diendorfer, Matthias Hackl, Matijs van Meurs, Grietje Molema
{"title":"Unique miRNome and transcriptome profiles underlie microvascular heterogeneity in mouse kidney.","authors":"Matthijs Luxen, Peter J Zwiers, Femke Meester, Rianne M Jongman, Timara Kuiper, Jill Moser, Marianne Pultar, Susanna Skalicky, Andreas B Diendorfer, Matthias Hackl, Matijs van Meurs, Grietje Molema","doi":"10.1152/ajprenal.00005.2023","DOIUrl":"10.1152/ajprenal.00005.2023","url":null,"abstract":"<p><p>Endothelial cells in blood vessels in the kidney exert different functions depending on the (micro)vascular bed they are located in. The present study aimed to investigate microRNA and mRNA transcription patterns that underlie these differences. We zoomed in on microvascular compartments in the mouse renal cortex by laser microdissecting the microvessels prior to small RNA- and RNA-sequencing analyses. By these means, we characterized microRNA and mRNA transcription profiles of arterioles, glomeruli, peritubular capillaries, and postcapillary venules. Quantitative RT-PCR, in situ hybridization, and immunohistochemistry were used to validate sequencing results. Unique microRNA and mRNA transcription profiles were found in all microvascular compartments, with dedicated marker microRNAs and mRNAs showing enriched transcription in a single microvascular compartment. In situ hybridization validated the localization of microRNAs mmu-miR-140-3p in arterioles, mmu-miR-322-3p in glomeruli, and mmu-miR-451a in postcapillary venules. Immunohistochemical staining showed that von Willebrand factor protein was mainly expressed in arterioles and postcapillary venules, whereas GABRB1 expression was enriched in glomeruli, and IGF1 was enriched in postcapillary venules. More than 550 compartment-specific microRNA-mRNA interaction pairs were identified that carry functional implications for microvascular behavior. In conclusion, our study identified unique microRNA and mRNA transcription patterns in microvascular compartments of the mouse kidney cortex that underlie microvascular heterogeneity. These patterns provide important molecular information for future studies into differential microvascular engagement in health and disease.<b>NEW & NOTEWORTHY</b> Renal endothelial cells display a high level of heterogeneity depending on the (micro)vascular bed they reside in. The molecular basis contributing to these differences is poorly understood yet of high importance to increase understanding of microvascular engagement in the kidney in health and disease. This report describes m(icro)RNA expression profiles of microvascular beds in the mouse renal cortex and uncovers microvascular compartment-specific m(icro)RNAs and miRNA-mRNA pairs, thereby revealing important molecular mechanisms underlying renal microvascular heterogeneity.</p>","PeriodicalId":7588,"journal":{"name":"American Journal of Physiology-renal Physiology","volume":"325 3","pages":"F299-F316"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511173/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rikeish R Muralitharan, Matthew Snelson, Guillaume Meric, Melinda T Coughlan, Francine Z Marques
{"title":"Guidelines for microbiome studies in renal physiology.","authors":"Rikeish R Muralitharan, Matthew Snelson, Guillaume Meric, Melinda T Coughlan, Francine Z Marques","doi":"10.1152/ajprenal.00072.2023","DOIUrl":"https://doi.org/10.1152/ajprenal.00072.2023","url":null,"abstract":"<p><p>Gut microbiome research has increased dramatically in the last decade, including in renal health and disease. The field is moving from experiments showing mere association to causation using both forward and reverse microbiome approaches, leveraging tools such as germ-free animals, treatment with antibiotics, and fecal microbiota transplantations. However, we are still seeing a gap between discovery and translation that needs to be addressed, so that patients can benefit from microbiome-based therapies. In this guideline paper, we discuss the key considerations that affect the gut microbiome of animals and clinical studies assessing renal function, many of which are often overlooked, resulting in false-positive results. For animal studies, these include suppliers, acclimatization, baseline microbiota and its normalization, littermates and cohort/cage effects, diet, sex differences, age, circadian differences, antibiotics and sweeteners, and models used. Clinical studies have some unique considerations, which include sampling, gut transit time, dietary records, medication, and renal phenotypes. We provide best-practice guidance on sampling, storage, DNA extraction, and methods for microbial DNA sequencing (both 16S rRNA and shotgun metagenome). Finally, we discuss follow-up analyses, including tools available, metrics, and their interpretation, and the key challenges ahead in the microbiome field. By standardizing study designs, methods, and reporting, we will accelerate the findings from discovery to translation and result in new microbiome-based therapies that may improve renal health.</p>","PeriodicalId":7588,"journal":{"name":"American Journal of Physiology-renal Physiology","volume":"325 3","pages":"F345-F362"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10047257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fernanda Florencia Fregnan Zambom, Amanda Helen Albino, Helena Mendonça Tessaro, Orestes Foresto-Neto, Denise Maria Avancini Costa Malheiros, Niels Olsen Saraiva Camara, Roberto Zatz
{"title":"Chronic environmental hypoxia attenuates innate immunity activation and renal injury in two CKD models.","authors":"Fernanda Florencia Fregnan Zambom, Amanda Helen Albino, Helena Mendonça Tessaro, Orestes Foresto-Neto, Denise Maria Avancini Costa Malheiros, Niels Olsen Saraiva Camara, Roberto Zatz","doi":"10.1152/ajprenal.00200.2022","DOIUrl":"https://doi.org/10.1152/ajprenal.00200.2022","url":null,"abstract":"<p><p>Tissue hypoxia has been pointed out as a major pathogenic factor in chronic kidney disease (CKD). However, epidemiological and experimental evidence inconsistent with this notion has been described. We have previously reported that chronic exposure to low ambient Po<sub>2</sub> promoted no renal injury in normal rats and in rats with 5/6 renal ablation (Nx) unexpectedly attenuated renal injury. In the present study, we investigated whether chronic exposure to low ambient Po<sub>2</sub> would also be renoprotective in two additional models of CKD: adenine (ADE) excess and chronic nitric oxide (NO) inhibition. In both models, normobaric ambient hypoxia attenuated the development of renal injury and inflammation. In addition, renal hypoxia limited the activation of NF-κB and NOD-like receptor family pyrin domain containing 3 inflammasome cascades as well as oxidative stress and intrarenal infiltration by angiotensin II-positive cells. Renal activation of hypoxia-inducible factor (HIF)-2α, along with other adaptive mechanisms to hypoxia, may have contributed to these renoprotective effects. The present findings may contribute to unravel the pathogenesis of CKD and to the development of innovative strategies to arrest its progression.<b>NEW & NOTEWORTHY</b> Hypoxia is regarded as a major pathogenic factor in chronic kidney disease (CKD). In disagreement with this view, we show here that sustained exposure to low ambient Po<sub>2</sub> lessened kidney injury and inflammation in two CKD models: adenine (ADE) excess and chronic nitric oxide (NO) inhibition. Together with our previous findings in the remnant kidney, these observations indicate that local changes elicited by hypoxia may exert renoprotection in CKD, raising the prospect of novel therapeutic strategies for this disease.</p>","PeriodicalId":7588,"journal":{"name":"American Journal of Physiology-renal Physiology","volume":"325 3","pages":"F283-F298"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ubong S Ekperikpe, Sautan Mandal, Stephen J Holt, Jacori K Daniels, Tyler D Johnson, Jonita S Cooper, Sarah M Safir, Denise C Cornelius, Jan M Williams
{"title":"Metformin reduces insulin resistance and attenuates progressive renal injury in prepubertal obese Dahl salt-sensitive rats.","authors":"Ubong S Ekperikpe, Sautan Mandal, Stephen J Holt, Jacori K Daniels, Tyler D Johnson, Jonita S Cooper, Sarah M Safir, Denise C Cornelius, Jan M Williams","doi":"10.1152/ajprenal.00078.2023","DOIUrl":"10.1152/ajprenal.00078.2023","url":null,"abstract":"<p><p>Prepubertal obesity is currently an epidemic and is considered as a major risk factor for renal injury. Previous studies have demonstrated that insulin resistance contributes to renal injury in obesity, independent of diabetes. However, studies examining the relationship between insulin resistance and renal injury in obese children are lacking. Recently, we reported that progressive renal injury in Dahl salt-sensitive (SS) leptin receptor mutant (SS<sup>LepR</sup>mutant) rats was associated with insulin resistance before puberty. Therefore, the aim of the present study was to examine whether decreasing insulin resistance with metformin will reduce renal injury in SS<sup>LepR</sup>mutant rats. Four-wk-old SS and SS<sup>LepR</sup>mutant rats were separated into the following two groups: <i>1</i>) vehicle and <i>2</i>) metformin (300 mg/kg/day) via chow diet for 4 wk. Chronic administration of metformin markedly reduced insulin resistance and dyslipidemia in SS<sup>LepR</sup>mutant rats. We did not detect any differences in mean arterial pressure between vehicle and metformin-treated SS and SS<sup>LepR</sup>mutant rats. Proteinuria was significantly greater in SS<sup>LepR</sup>mutant rats versus SS rats throughout the study, and metformin administration significantly reduced proteinuria in SS<sup>LepR</sup>mutant rats. At the end of the protocol, metformin prevented the renal hyperfiltration observed in SS<sup>LepR</sup>mutant rats versus SS rats. Glomerular and tubular injury and renal inflammation and fibrosis were significantly higher in vehicle-treated SS<sup>LepR</sup>mutant rats versus SS rats, and metformin reduced these parameters in SS<sup>LepR</sup>mutant rats. These data suggest that reducing insulin resistance with metformin prevents renal hyperfiltration and progressive renal injury in SS<sup>LepR</sup>mutant rats before puberty and may be therapeutically useful in managing renal injury during prepubertal obesity.<b>NEW & NOTEWORTHY</b> Childhood/prepubertal obesity is a public health concern that is associated with early signs of proteinuria. Insulin resistance has been described in obese children. However, studies investigating the role of insulin resistance during childhood obesity-associated renal injury are limited. This study provides evidence of an early relationship between insulin resistance and renal injury in a rat model of prepubertal obesity. These data also suggest that reducing insulin resistance with metformin may be renoprotective in obese children.</p>","PeriodicalId":7588,"journal":{"name":"American Journal of Physiology-renal Physiology","volume":"325 3","pages":"F363-F376"},"PeriodicalIF":3.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10639024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10074564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Isha S Dhande, Yaming Zhu, Aniket S Joshi, M John Hicks, Michael C Braun, Peter A Doris
{"title":"Polygenic genetic variation affecting antibody formation underlies hypertensive renal injury in the stroke-prone spontaneously hypertensive rat.","authors":"Isha S Dhande, Yaming Zhu, Aniket S Joshi, M John Hicks, Michael C Braun, Peter A Doris","doi":"10.1152/ajprenal.00058.2023","DOIUrl":"10.1152/ajprenal.00058.2023","url":null,"abstract":"<p><p>During development of the spontaneously hypertensive rat (SHR), several distinct but closely related lines were generated. Most lines are resistant to hypertensive renal disease. However, the SHR-A3 line (stroke-prone SHR) experiences end-organ injury (EOI) and provides a model of injury susceptibility that can be used to uncover genetic causation. In the present study, we generated a congenic line in which three distinct disease loci in SHR-A3 are concurrently replaced with homologous loci from an injury-resistant SHR line (SHR-B2). Verification that all three loci were homozygously replaced in this triple congenic line [SHR-A3(Trip B2)] while the genetic background of SHR-A3 was fully retained was obtained by whole genome sequencing. Congenic genome substitution was without effect on systolic blood pressure [198.9 ± 3.34 mmHg, mean ± SE, SHR-A3(Trip B2) = 194.7 ± 2.55 mmHg]. Measures of renal injury (albuminuria, histological injury scores, and urinary biomarker levels) were reduced in SHR-A3(Trip B2) animals, even though only 4.5 Mbases of the 2.8 Gbases of the SHR-B2 genome (0.16% of the genome) was transferred into the congenic line. The gene content of the three congenic loci and the functional effects of gene polymorphism within suggest a role of immunoglobulin in EOI pathogenesis. To prove the role of antibodies in EOI in SHR-A3, we generated an SHR-A3 line in which expression from the immunoglobulin heavy chain gene was knocked out (SHR-A3-IGHKO). Animals in the SHR-A3-IGHKO line lack B cells and immunoglobulin, but the hypertensive phenotype is not affected. Renal injury, however, was reduced in this line, confirming a pathogenic role for immunoglobulin in hypertensive EOI in this model of heritable risk.<b>NEW & NOTEWORTHY</b> Here, we used a polygenic animal model of hypertensive renal disease to show that genetic variation affecting antibody formation underlies hypertensive renal disease. We proved the genetic thesis by generating an immunoglobulin knockout in the susceptible animal model.</p>","PeriodicalId":7588,"journal":{"name":"American Journal of Physiology-renal Physiology","volume":"325 3","pages":"F317-F327"},"PeriodicalIF":3.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jesus S Neyra, Silvia Medrano, Alexandre De Goes Martini, Maria Luisa S Sequeira-Lopez, R Ariel Gomez
{"title":"The role of Gata3 in renin cell identity.","authors":"Jesus S Neyra, Silvia Medrano, Alexandre De Goes Martini, Maria Luisa S Sequeira-Lopez, R Ariel Gomez","doi":"10.1152/ajprenal.00098.2023","DOIUrl":"10.1152/ajprenal.00098.2023","url":null,"abstract":"<p><p>Renin cells are precursors for other cell types in the kidney and show high plasticity in postnatal life in response to challenges to homeostasis. Our previous single-cell RNA-sequencing studies revealed that the dual zinc-finger transcription factor <i>Gata3</i>, which is important for cell lineage commitment and differentiation, is expressed in mouse renin cells under normal conditions and homeostatic threats. We identified a potential Gata3-binding site upstream of the renin gene leading us to hypothesize that <i>Gata3</i> is essential for renin cell identity. We studied adult mice with conditional deletion of <i>Gata3</i> in renin cells: <i>Gata3<sup>fl/fl</sup></i>;<i>Ren1<sup>dCre/+</sup></i> (<i>Gata3-cKO</i>) and control Gata3<i><sup>fl/fl</sup></i>;<i>Ren1<sup>d+/+</sup></i> counterparts. Gata3 immunostaining revealed that <i>Gata3-cKO</i> mice had significantly reduced Gata3 expression in juxtaglomerular, mesangial, and smooth muscle cells, indicating a high degree of deletion of <i>Gata3</i> in renin lineage cells. <i>Gata3-cKO</i> mice exhibited a significant increase in blood urea nitrogen, suggesting hypovolemia and/or compromised renal function. By immunostaining, renin-expressing cells appeared very thin compared with their normal plump shape in control mice. Renin cells were ectopically localized to Bowman's capsule in some glomeruli, and there was aberrant expression of actin-α<sub>2</sub> signals in the mesangium, interstitium, and Bowman's capsule in <i>Gata3-cKO</i> mice. Distal tubules showed dilated morphology with visible intraluminal casts. Under physiological threat, <i>Gata3-cKO</i> mice exhibited a lower increase in mRNA levels than controls. Hematoxylin-eosin, periodic acid-Schiff, and Masson's trichrome staining showed increased glomerular fusion, absent cubical epithelial cells in Bowman's capsule, intraglomerular aneurysms, and tubular dilation. In conclusion, our results indicate that <i>Gata3</i> is crucial to the identity of cells of the renin lineage.<b>NEW & NOTEWORTHY</b> <i>Gata3</i>, a dual zinc-finger transcription factor, is responsible for the identity and localization of renin cells in the kidney. Mice with a conditional deletion of <i>Gata3</i> in renin lineage cells have abnormal kidneys with juxtaglomerular cells that lose their characteristic location and are misplaced outside and around arterioles and glomeruli. The fundamental role of <i>Gata3</i> in renin cell development offers a new model to understand how transcription factors control cell location, function, and pathology.</p>","PeriodicalId":7588,"journal":{"name":"American Journal of Physiology-renal Physiology","volume":"325 2","pages":"F188-F198"},"PeriodicalIF":3.7,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10101551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}